Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED to Outpatient Naltrexone for AUD
NCT05228418Phase 4Unknown
- Sponsor
- Einstein Healthcare Network
- Start
- Mar 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in alcohol use disorder (AUD), sponsored by Einstein Healthcare Network. Status: unknown.
02
Drugs
naltrexone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT05228418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05228418.